HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma.

Abstract
Drug resistance and relapse remain key challenges in pancreatic cancer. Here, we have used RNA sequencing (RNA-seq), chromatin immunoprecipitation (ChIP)-seq, and genome-wide CRISPR analysis to map the molecular dependencies of pancreatic cancer stem cells, highly therapy-resistant cells that preferentially drive tumorigenesis and progression. This integrated genomic approach revealed an unexpected utilization of immuno-regulatory signals by pancreatic cancer epithelial cells. In particular, the nuclear hormone receptor retinoic-acid-receptor-related orphan receptor gamma (RORĪ³), known to drive inflammation and T cell differentiation, was upregulated during pancreatic cancer progression, and its genetic or pharmacologic inhibition led to a striking defect in pancreatic cancer growth and a marked improvement in survival. Further, a large-scale retrospective analysis in patients revealed that RORĪ³ expression may predict pancreatic cancer aggressiveness, as it positively correlated with advanced disease and metastasis. Collectively, these data identify an orthogonal co-option of immuno-regulatory signals by pancreatic cancer stem cells, suggesting that autoimmune drugs should be evaluated as novel treatment strategies for pancreatic cancer patients.
AuthorsNikki K Lytle, L Paige Ferguson, Nirakar Rajbhandari, Kathryn Gilroy, Raymond G Fox, Anagha Deshpande, Christian M Schürch, Michael Hamilton, Neil Robertson, Wei Lin, Pawan Noel, Martin Wartenberg, Inti Zlobec, Micha Eichmann, José A Galván, Eva Karamitopoulou, Tami Gilderman, Lourdes Adriana Esparza, Yutaka Shima, Philipp Spahn, Randall French, Nathan E Lewis, Kathleen M Fisch, Roman Sasik, Sara Brin Rosenthal, Marcie Kritzik, Daniel Von Hoff, Haiyong Han, Trey Ideker, Aniruddha J Deshpande, Andrew M Lowy, Peter D Adams, Tannishtha Reya
JournalCell (Cell) Vol. 177 Issue 3 Pg. 572-586.e22 (04 18 2019) ISSN: 1097-4172 [Electronic] United States
PMID30955884 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 Elsevier Inc. All rights reserved.
Chemical References
  • Cell Adhesion Molecules
  • Nuclear Receptor Subfamily 1, Group F, Member 3
  • RNA, Small Interfering
  • Receptors, G-Protein-Coupled
  • Receptors, Interleukin-10
Topics
  • Adenocarcinoma (genetics, metabolism, pathology)
  • Animals
  • Cell Adhesion Molecules (genetics, metabolism)
  • Cell Differentiation
  • Epigenesis, Genetic
  • Gene Library
  • Humans
  • Mice
  • Mice, Knockout
  • Mice, SCID
  • Neoplastic Stem Cells (cytology, metabolism)
  • Nuclear Receptor Subfamily 1, Group F, Member 3 (antagonists & inhibitors, genetics, metabolism)
  • Pancreatic Neoplasms (genetics, metabolism, pathology)
  • RNA Interference
  • RNA, Small Interfering (metabolism)
  • Receptors, G-Protein-Coupled (antagonists & inhibitors, genetics, metabolism)
  • Receptors, Interleukin-10 (antagonists & inhibitors, genetics, metabolism)
  • T-Lymphocytes (cytology, immunology, metabolism)
  • Transcriptome
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: